GKOS vs. BAX, SWAV, PODD, SOLV, TFX, GMED, PEN, MMSI, INSP, and HAE
Should you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Baxter International (BAX), Shockwave Medical (SWAV), Insulet (PODD), Solventum (SOLV), Teleflex (TFX), Globus Medical (GMED), Penumbra (PEN), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), and Haemonetics (HAE). These companies are all part of the "surgical & medical instruments" industry.
Baxter International (NYSE:BAX) and Glaukos (NYSE:GKOS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment.
Baxter International has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.
Baxter International has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
Baxter International received 303 more outperform votes than Glaukos when rated by MarketBeat users. Likewise, 66.12% of users gave Baxter International an outperform vote while only 64.59% of users gave Glaukos an outperform vote.
Baxter International currently has a consensus target price of $44.42, suggesting a potential upside of 30.29%. Glaukos has a consensus target price of $109.55, suggesting a potential downside of 2.82%. Given Glaukos' higher possible upside, equities research analysts clearly believe Baxter International is more favorable than Glaukos.
In the previous week, Baxter International had 10 more articles in the media than Glaukos. MarketBeat recorded 18 mentions for Baxter International and 8 mentions for Glaukos. Glaukos' average media sentiment score of 0.46 beat Baxter International's score of 0.38 indicating that Baxter International is being referred to more favorably in the media.
90.2% of Baxter International shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 6.4% of Glaukos shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Baxter International has a net margin of 17.79% compared to Baxter International's net margin of -43.15%. Glaukos' return on equity of 18.47% beat Baxter International's return on equity.
Summary
Baxter International beats Glaukos on 12 of the 18 factors compared between the two stocks.
Get Glaukos News Delivered to You Automatically
Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GKOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
